Z79.810
Long term (current) use of selective estrogen receptor modulators (SERMs)
Clinical Classification Guidelines
Inclusion Terms
- Long term (current) use of raloxifene (Evista)
- Long term (current) use of tamoxifen (Nolvadex)
- Long term (current) use of toremifene (Fareston)
Medical Intelligence & Overview
The long-term use of Selective Estrogen Receptor Modulators (SERMs) refers to ongoing medication therapy with drugs like raloxifene, tamoxifen, or toremifene. These medications are primarily prescribed for conditions related to hormone-sensitive tissues, especially in managing breast cancer risk and osteoporosis in postmenopausal women. While effective, prolonged use of SERMs requires careful consideration and management due to potential side effects and health implications.
Causes & Symptoms
Clinical Causes: Prevention or treatment of hormone-sensitive breast cancer Management of osteoporosis in postmenopausal women Reducing the risk of invasive breast cancer in high-risk women Prophylactic use in women with increased breast cancer risk
Key Symptoms: Hot flashes and night sweats Vaginal dryness or discomfort Fatigue Muscle or joint aches Changes in bone density Blood clotting issues, such as deep vein thrombosis (DVT) or pulmonary embolism Potential for endometrial changes, including bleeding or hyperplasia
Diagnostic & Treatment
Diagnosis Path: Diagnosis of long-term SERM use is based on medical history, prescription records, and vigilance for associated side effects. Healthcare providers monitor patient response and health status through regular clinical evaluations, blood tests to assess blood clotting risks, bone density scans, and imaging as needed. It's important for patients to inform healthcare providers about their medication history and any new symptoms experienced during therapy.
Treatment Protocols: Regular follow-up appointments to monitor for side effects and assess therapy effectiveness Bone health management, including periodic bone density measurements Screening for blood clots, especially in individuals with risk factors Addressing menopausal symptoms like hot flashes through safe measures Patient education on recognizing symptoms of blood clots or abnormal bleeding Adjusting medication if adverse effects occur Ensuring proper lifestyle choices, such as maintaining healthy weight, regular exercise, and smoking cessation to support overall health
Clinical Advice & FAQs
Billing Guidance
Is Z79.810 a billable ICD-10 code?
Yes, Z79.810 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z79.810?
Clinical documentation must specify the nature of Long term (current) use of selective estrogen receptor modulators (SERMs) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference